Millennium Pharma 3Q

Millennium Pharmaceuticals

3Q Revenues: $122 million (+18%)

3Q Loss: $1.7 million (loss of $13.7 million in 3Q06)

YTD Revenues: $346 million (flat)

YTD Loss: $26.2 million (loss of $52.2 million in YTD06)

Comments: U.S. net sales of Velcade grew 32% to $70 million in 3Q07 and royalty revenues were up 23% to $41.3 million. The company attributes some of its net YTD loss to amortization of intangibles ($34 million), stock-based compensation ($25 million) and restructuring charges ($15 million).